{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:52:01Z","timestamp":1775022721311,"version":"3.50.1"},"reference-count":58,"publisher":"Universidad de Santander - UDES","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["udes.edu.co"],"crossmark-restriction":true},"short-container-title":["Rev Cuid"],"abstract":"<jats:p>Introducci\u00f3n: la baja visi\u00f3n y la ceguera tienen alta prevalencia mundial, siendo categor\u00edas de discapacidad frecuentes en Colombia. Se requieren estudios que caractericen la etiolog\u00eda de las deficiencias visuales permanentes. Objetivo: Identificar y caracterizar las diferentes causas de baja visi\u00f3n y ceguera en siete centros de referencia para la poblaci\u00f3n con discapacidad visual en Colombia, atendida entre los a\u00f1os 2012 a 2017 en seis ciudades capitales. Materiales y m\u00e9todos: estudio retrospectivo, serie de casos, descriptivo y multic\u00e9ntrico. Resultados: Se cont\u00f3 con una muestra de 879 registros de pacientes con discapacidad visual. El 70% (612\/879) con baja visi\u00f3n y 30% (267\/879) con ceguera. Para todos los grupos de edad es m\u00e1s prevalente la baja visi\u00f3n. La etiolog\u00eda m\u00e1s frecuente en pacientes con baja visi\u00f3n fue la degeneraci\u00f3n macular asociada a la edad (DMAE) (24%, 144\/612); en pacientes con ceguera fue el glaucoma (17%, 45\/267). Discusi\u00f3n: Posiblemente en Colombia las causas de baja visi\u00f3n y ceguera van m\u00e1s all\u00e1 de las cataratas, errores de refracci\u00f3n no corregidos y ceguera infecciosa. Conclusiones: las etiolog\u00edas m\u00e1s frecuentes encontradas son condiciones oculares cr\u00f3nicas y diversas, que requieren intervenciones espec\u00edficas para disminuir su prevalencia y prevenir casos de baja visi\u00f3n y ceguera.<\/jats:p>","DOI":"10.15649\/cuidarte.2036","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T16:26:03Z","timestamp":1651681563000},"update-policy":"https:\/\/doi.org\/10.15649\/cuidarte.crossmark","source":"Crossref","is-referenced-by-count":7,"title":["Etiolog\u00eda de baja visi\u00f3n y ceguera en siete centros de referencia en Colombia entre los a\u00f1os 2012 a 2017"],"prefix":"10.15649","author":[{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0716-561X","authenticated-orcid":false,"given":"Juan Camilo","family":"Su\u00e1rez Escudero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-8409","authenticated-orcid":false,"given":"Mar\u00eda del Pilar","family":"Oviedo C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Santo Tom\u00e1s-Bucaramanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2125-8620","authenticated-orcid":false,"given":"Yuliana","family":"Llano Naranjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7808-0712","authenticated-orcid":false,"given":"Johana","family":"Arias Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9726-0911","authenticated-orcid":false,"given":"Jos\u00e9 Daniel","family":"Villegas Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7693-231X","authenticated-orcid":false,"given":"Mar\u00eda Camila","family":"Zapata V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-3743","authenticated-orcid":false,"given":"Jorge Luis","family":"Ferreira Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8340-9765","authenticated-orcid":false,"given":"Jessica Tatiana","family":"Reyes Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3160-5339","authenticated-orcid":false,"given":"Karen","family":"Cano Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB). Medell\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3404-6221","authenticated-orcid":false,"given":"Sydney","family":"Goldfeder de Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0304-6835","authenticated-orcid":false,"given":"Juan Felipe","family":"Gonz\u00e1lez Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-6394","authenticated-orcid":false,"given":"Esau","family":"Astudillo Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Universidad Pontificia Bolivariana (UPB)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6285","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"38472","unstructured":"Organizaci\u00f3n Mundial de la Salud. Informe mundial sobre la discapacidad. WHO. 2011. https:\/\/www.afro.who.int\/sites\/default\/files\/2017-06\/9789240688230_spa.pdf"},{"key":"38473","unstructured":"Organizaci\u00f3n Mundial de la Salud, Banco Mundial. Resumen: Informe mundial sobre la discapacidad. WHO. 2011. https:\/\/www.oas.org\/es\/sedi\/ddse\/paginas\/documentos\/discapacidad\/DESTACADOS\/ResumenInformeMundial.pdf"},{"key":"38474","doi-asserted-by":"crossref","unstructured":"Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(9): e888\u2013e897. https:\/\/doi.org\/10.1016\/S2214-109X(17)30293-0","DOI":"10.1016\/S2214-109X(17)30293-0"},{"key":"38475","unstructured":"Organizaci\u00f3n Mundial de la Salud. Blindness and vision impairment. WHO. 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment"},{"key":"38476","doi-asserted-by":"crossref","unstructured":"Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones L, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. The Lancet Global Health. 2021: 9 (4) e489-551. https:\/\/doi.org\/10.1016\/S2214-109X(20)30488-5","DOI":"10.1016\/S2214-109X(20)30488-5"},{"key":"38477","doi-asserted-by":"crossref","unstructured":"Bourne R, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. The Lancet Global Health. 2021; 9(2): e130\u2013e143. https:\/\/doi.org\/10.1016\/S2214-109X(20)30425-3","DOI":"10.1016\/S2214-109X(20)30425-3"},{"key":"38478","unstructured":"Organizaci\u00f3n Mundial de la Salud. Vision impairment and blindness. WHO. 2018. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment"},{"key":"38479","doi-asserted-by":"crossref","unstructured":"Fricke TR, Tahhan N, Resnikoff S, Papas E, Burnett A, Ho SM et al. Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling. Ophthalmology. 2018; 125(10): 1492\u20131499. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.013","DOI":"10.1016\/j.ophtha.2018.04.013"},{"key":"38480","doi-asserted-by":"crossref","unstructured":"Leasher JL, Braithwaite T, Furtado JM, Flaxman SR, Lansingh VC, Silva JC et al. Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections. Br J Ophthalmol. 2019; 103(7): 885\u2013893. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311746","DOI":"10.1136\/bjophthalmol-2017-311746"},{"key":"38481","doi-asserted-by":"crossref","unstructured":"Leasher JL, Lansingh V, Flaxman SR, Jonas JB, Keeffe J, Naidoo Kovin, et al. Prevalence and causes of vision loss in Latin America and the Caribbean: 1990-2010. Br J Ophthalmol. 2014; 98: 619\u2013628. http:\/\/dx.doi.org\/10.1136\/bjophthalmol-2013-304013","DOI":"10.1136\/bjophthalmol-2013-304013"},{"key":"38482","unstructured":"Departamento Administrativo Nacional de Estad\u00edstica. Censo general 2005: Discapacidad personas con limitaciones permanentes. DANE. https:\/\/www.dane.gov.co\/files\/censos\/discapacidad\/discapacidad_mundo.pdf?phpMyAdmin=a9ticq8rv198vhk5e8cck52r11%2c3om27vamm65hhkhrtgc8rrn2g4&msclkid=12dd5fb4c4af11ec8be7d9be0a110fc4"},{"key":"38483","unstructured":"Departamento Administrativo Nacional de Estad\u00edstica. Personas con Discapacidad, retos diferenciales en el marco del COVID-19. DANE. 2020. https:\/\/www.dane.gov.co\/files\/investigaciones\/discapacidad\/2020-Boletin-personas-con-discapacidad-marco-COVID-19.pdf"},{"key":"38484","doi-asserted-by":"crossref","unstructured":"K\u00f6berlein J, Beifus K, Schaffert C, Finger RP. The economic burden of visual impairment and blindness: a systematic review. BMJ Open. 2013; 3(11): e003471. http:\/\/dx.doi.org\/10.1136\/bmjopen-2013-003471","DOI":"10.1136\/bmjopen-2013-003471"},{"key":"38485","doi-asserted-by":"crossref","unstructured":"Wang W, Yan W, M\u00fcller A, Keel S, He M. Association of Socioeconomics With Prevalence of Visual Impairment and Blindness. JAMA Ophthalmol. 2017; 135(12): 1295\u20131302. http:\/\/dx.doi.org\/10.1001\/jamaophthalmol.2017.3449","DOI":"10.1001\/jamaophthalmol.2017.3449"},{"key":"38486","doi-asserted-by":"crossref","unstructured":"Brody BL, Gamst AC, Williams RA, Smith AR, Lau MA PW, Dolnak DO D, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001; 108 (10): 1893\u20131900. http:\/\/dx.doi.org\/10.1016\/s0161-6420(01)00754-0","DOI":"10.1016\/S0161-6420(01)00754-0"},{"key":"38487","doi-asserted-by":"crossref","unstructured":"Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998; 116(4): 514\u2013520. http:\/\/dx.doi.org\/10.1001\/archopht.116.4.514","DOI":"10.1001\/archopht.116.4.514"},{"key":"38488","unstructured":"Organizaci\u00f3n Mundial de la Salud. Programme for the Prevention of Blindness and Deafness.2000\u200e. Global initiative for the elimination of avoidable blindness. WHO. 2000. https:\/\/apps.who.int\/iris\/handle\/10665\/63748"},{"key":"38489","unstructured":"Organizaci\u00f3n Mundial de la Salud. Salud ocular universal: un plan de acci\u00f3n mundial para 2014-2019. WHO. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/105956\/9789243506562_spa.pdf?sequence=1&isAllowed=y"},{"key":"38490","doi-asserted-by":"crossref","unstructured":"Arias-Uribe J, Llano-Naranjo Y, Astudillo-Valverde E, Su\u00e1rez-Escudero JC. Caracterizaci\u00f3n cl\u00ednica y etiolog\u00eda de baja visi\u00f3n y ceguera en una poblaci\u00f3n adulta con discapacidad visual. Rev Mex Oftalmol. 2019; 92: 201\u2013208. https:\/\/www.medigraphic.com\/pdfs\/revmexoft\/rmo-2018\/rmo184e.pdf","DOI":"10.24875\/RMO.M18000033"},{"key":"38491","unstructured":"Galvis Ram\u00edrez V, Rey Serrano JJ, Rodr\u00edguez Villamizar LA, Calder\u00f3n C, Hern\u00e1ndez A. Prevalencia de ceguera en el departamento de Santander - Colombia. MedUNAB. 2009; 12(2): 66\u201373. https:\/\/revistas.unab.edu.co\/index.php\/medunab\/article\/view\/32\/30"},{"key":"38492","unstructured":"Organizaci\u00f3n Mundial de la Salud. International Statistical Classification of Diseases and Related Health Problems (ICD). WHO. 2022. http:\/\/www.who.int\/classifications\/icd\/icdonlineversions\/en\/"},{"key":"38493","doi-asserted-by":"crossref","unstructured":"Lavrakas P. Encyclopedia of Survey Research Methods. SAGE. 2008. http:\/\/dx.doi.org\/10.4135\/9781412963947","DOI":"10.4135\/9781412963947"},{"key":"38494","unstructured":"Lwanga SK, Lemeshow S. Determinaci\u00f3n del tama\u00f1o de las muestras en los estudios sanitarios. Manual pr\u00e1ctico. Organizaci\u00f3n Mundial de la Salud. 1991. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/37589\/9243544055_spa.pdf?sequence=1&isAllowed=y"},{"key":"38495","unstructured":"Su\u00e1rez Escudero, JC. Base datos etiologia discapacidad visual Colombia multicentrico. Mendeley Data. 2022. https:\/\/doi.org\/10.17632\/y4c2x2s8mj.1"},{"key":"38496","doi-asserted-by":"crossref","unstructured":"Oviedo MP, Hern\u00e1ndez ML, Ru\u00edz M. Baja visi\u00f3n en Colombia: una situaci\u00f3n invisible para el pa\u00eds. Rev. Fac. Nac. Salud P\u00fablica. 2015; 33(1):22-30. http:\/\/www.scielo.org.co\/pdf\/rfnsp\/v33n1\/v33n1a04.pdf","DOI":"10.17533\/udea.rfnsp.16499"},{"key":"38497","unstructured":"Padilla MLH, C\u00e1ceres M del PO, Rodr\u00edguez MR. Organizaci\u00f3n y gesti\u00f3n de la red de atenci\u00f3n para la baja visi\u00f3n en Colombia. Investig. andina. 2014; 16(29); 1100\u20131117. http:\/\/www.scielo.org.co\/scielo.php?script=sci_arttext&pid=S0124-81462014000200009"},{"key":"38498","unstructured":"Moreno Angarita M. Realidad y contexto situacional de la poblaci\u00f3n con limitaci\u00f3n visual en Colombia. una aproximaci\u00f3n desde la justicia y el desarrollo humano. Primera edici\u00f3n. Bogot\u00e1 D.C.: Instituto Nacional para Ciegos. 2012. https:\/\/www.coursehero.com\/file\/58016091\/libro-idh-inci-publicadopdf\/"},{"key":"38499","unstructured":"Organizaci\u00f3n Mundial de la Salud. Ceguera y discapacidad visual. WHO. 2021. http:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment"},{"key":"38500","unstructured":"Fedesarrollo, Fundaci\u00f3n Saldarriaga Concha, Villar L, Mart\u00ednez-Restrepo S, Guti\u00e9rrez C, Forero D. Misi\u00f3n Colombia Envejece: cifras, retos y recomendaciones. Editorial Fundaci\u00f3n Saldarriaga Concha. 2015. https:\/\/www.repository.fedesarrollo.org.co\/handle\/11445\/2724"},{"key":"38501","doi-asserted-by":"crossref","unstructured":"Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5: e888\u2013e897. http:\/\/dx.doi.org\/10.1016\/S2214-109X(17)30293-0","DOI":"10.1016\/S2214-109X(17)30293-0"},{"key":"38502","doi-asserted-by":"crossref","unstructured":"Rius A, Lansingh VC, Valencia LG, Carter M, Eckert K. Social inequalities in blindness and visual impairment: A review of social determinants. IJO. 2012; 60: 368-375. http:\/\/dx.doi.org\/10.4103\/0301-4738.100529","DOI":"10.4103\/0301-4738.100529"},{"key":"38503","doi-asserted-by":"crossref","unstructured":"Clayton JA, Davis AF. Sex\/Gender Disparities and Women\u2019s Eye Health. Current Eye Research. 2015; 40 (2): 102\u2013109. http:\/\/dx.doi.org\/10.3109\/02713683.2014.986333","DOI":"10.3109\/02713683.2014.986333"},{"key":"38504","doi-asserted-by":"crossref","unstructured":"Doyal L, Das-Bhaumik RG. Sex, gender and blindness: a new framework for equity. BMJ Open Ophthalmology. 2018; 3(1): e000135. http:\/\/dx.doi.org\/10.1136\/bmjophth-2017-000135","DOI":"10.1136\/bmjophth-2017-000135"},{"key":"38505","unstructured":"Organizaci\u00f3n Panamericana de la Salud.Cifras de Ceguera en Latinoam\u00e9rica. VISI\u00d3N 2020. https:\/\/vision2020la.wordpress.com\/2014\/07\/14\/cifras-de-ceguera-en-latinoamerica\/"},{"key":"38506","doi-asserted-by":"crossref","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(12): e1221\u2013e1234. http:\/\/dx.doi.org\/10.1016\/S2214-109X(17)30393-5","DOI":"10.1016\/S2214-109X(17)30393-5"},{"key":"38507","doi-asserted-by":"crossref","unstructured":"Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004; 291(15): 1900\u20131901. http:\/\/dx.doi.org\/10.1001\/jama.291.15.1900","DOI":"10.1001\/jama.291.15.1900"},{"key":"38508","doi-asserted-by":"crossref","unstructured":"Spooner K, Hong T, Wijeyakumar W, Chang A. Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis. Clin Ophthalmol. 2017; 11: 161\u2013177. http:\/\/dx.doi.org\/10.2147\/OPTH.S125676","DOI":"10.2147\/OPTH.S125676"},{"key":"38509","doi-asserted-by":"crossref","unstructured":"Smith W, Assink J, Klein R, Mitchell P, Klaver CCW, Klein BEK, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001; 108(4): 697\u2013704. http:\/\/dx.doi.org\/10.1016\/s0161-6420(00)00580-7","DOI":"10.1016\/S0161-6420(00)00580-7"},{"key":"38510","doi-asserted-by":"crossref","unstructured":"Chong MF, Cho HH, Jackson AJ, Bentley SA. Profile of the Australian College of Optometry low vision clinic. Clin Exp Optom. 2018; 101(6): 793\u2013798. https:\/\/doi.org\/10.1111\/cxo.12805","DOI":"10.1111\/cxo.12805"},{"key":"38511","doi-asserted-by":"crossref","unstructured":"Wong WL, Su X, Li X, Cheung MG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2): e106-116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","DOI":"10.1016\/S2214-109X(13)70145-1"},{"key":"38512","doi-asserted-by":"crossref","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11): 2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"38513","doi-asserted-by":"crossref","unstructured":"Kapetanakis VV, Chan MPY, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016; 100(1): 86\u201393. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307223","DOI":"10.1136\/bjophthalmol-2015-307223"},{"key":"38514","doi-asserted-by":"crossref","unstructured":"Al-Merjan JI, Pandova MG, Al-Ghanim M, Al-Wayel A. Registered blindness and low vision in Kuwait. Ophthalmic Epidemiol. 2005; 12(4): 251\u2013257. https:\/\/doi.org\/10.1080\/09286580591005813","DOI":"10.1080\/09286580591005813"},{"key":"38515","doi-asserted-by":"crossref","unstructured":"Olusanya B, Onoja G, Ibraheem W, Bekibele C. Profile of patients presenting at a low vision clinic in a developing country. BMC Ophthalmol. 2012; 12: 31. https:\/\/doi.org\/10.1186\/1471-2415-12-31","DOI":"10.1186\/1471-2415-12-31"},{"key":"38516","doi-asserted-by":"crossref","unstructured":"Garweg JG. Ocular Toxoplasmosis: an Update. Klin Monbl Augenheilkd. 2016; 233: 534\u2013539. https:\/\/doi.org\/10.1055\/s-0041-111821","DOI":"10.1055\/s-0041-111821"},{"key":"38517","unstructured":"Nussenblatt RB, Whitcup SM. Uveitis. Fundamentals and Clinical Practice: Expert Consult. 4th Edition. MOSBY Elsevier. 2010. https:\/\/issuu.com\/japhsion\/docs\/uveitis__fundamentals_and_clinical_"},{"key":"38518","doi-asserted-by":"crossref","unstructured":"Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008; 2: e277. https:\/\/doi.org\/10.1371\/journal.pntd.0000277","DOI":"10.1371\/journal.pntd.0000277"},{"key":"38519","unstructured":"Facio Lince LA, L\u00f3pez de Mesa C, de-la Torre A. Toxoplasmosis ocular en Colombia: 10 a\u00f1os de aportes investigativos. Rev Soc Colomb Oftalmol. 2018; 51(1): 16\u201328. https:\/\/dialnet.unirioja.es\/servlet\/articulo?codigo=7025785"},{"key":"38520","doi-asserted-by":"crossref","unstructured":"Hartnett ME. Advances in understanding and management of retinopathy of prematurity. Surv Ophthalmol. 2017; 62(3): 257\u2013276. https:\/\/doi.org\/10.1016\/j.survophthal.2016.12.004","DOI":"10.1016\/j.survophthal.2016.12.004"},{"key":"38521","doi-asserted-by":"crossref","unstructured":"Todd DA, Wright A, Smith J. Severe retinopathy of prematurity in infants <30 weeks\u2019 gestation in New South Wales and the Australian Capital Territory from 1992 to 2002. Arch Dis Child Fetal Neonatal Ed. 2007; 92(4): F251-254. https:\/\/doi.org\/10.1136\/adc.2006.096479","DOI":"10.1136\/adc.2006.096479"},{"key":"38522","doi-asserted-by":"crossref","unstructured":"Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol. 2013; 40(2): 185\u2013200. https:\/\/doi.org\/10.1016\/j.clp.2013.02.001","DOI":"10.1016\/j.clp.2013.02.001"},{"key":"38523","doi-asserted-by":"crossref","unstructured":"Giraldo Restrepo MM, Hurtado Guzm\u00e1n A, Donado G\u00f3mez JH, Molina Betancur MC. Epidemiolog\u00eda de la retinopat\u00eda del prematuro en Medell\u00edn, 2003-2008. Iatreia. 2011; 24(3): 250\u2013258. http:\/\/www.scielo.org.co\/pdf\/iat\/v24n3\/v24n3a03.pdf","DOI":"10.17533\/udea.iatreia.10545"},{"key":"38524","doi-asserted-by":"crossref","unstructured":"Zuluaga C, Sierra MV, Asprilla E. Causas de ceguera infantil en Cali, Colombia. Colombia M\u00e9dica. 2005; 36(4): 235\u2013238. http:\/\/www.scielo.org.co\/scielo.php?script=sci_arttext&pid=S1657-95342005000400002#:~:text=La%20ROP%20es%20la%20principal,seguida%20por%20la%20toxoplasmosis%20ocular.","DOI":"10.25100\/cm.v36i.4.382"},{"key":"38525","unstructured":"Zin A. The increasing problem of retinopathy of prematurity. Community Eye Health. 2001; 14(40): 58\u201359. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1705951\/"},{"key":"38526","unstructured":"Ministerio de la Protecci\u00f3n Social Colombia. Lineamientos t\u00e9cnicos para la implementaci\u00f3n de programas madre canguro en Colombia. CODAJIC. 2009, http:\/\/www.codajic.org\/sites\/default\/files\/sites\/www.codajic.org\/files\/Lineamientos%20t%C3%A9cnicos%20para%20la%20implementaci%C3%B3n%20de%20Prgramas%20Madre%20Canguro%20.%20Colombia%202009.pdf"},{"key":"38527","doi-asserted-by":"crossref","unstructured":"Ohno-Matsui K, Lai TYY, Lai C-C, Gemmy Cheung CM. Updates of pathologic myopia. Prog Retin Eye Res. 2016; 52: 156\u2013187. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.12.001","DOI":"10.1016\/j.preteyeres.2015.12.001"},{"key":"38528","doi-asserted-by":"crossref","unstructured":"Cotter SA, Varma R, Ying-Lai M, Azen SP, Klein R. Causes of low vision and blindness in adult Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2006; 113(9): 1574\u20131582. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.002","DOI":"10.1016\/j.ophtha.2006.05.002"},{"key":"38529","doi-asserted-by":"crossref","unstructured":"Zhang X, Saaddine JB, Chou C-F, Cotch MF, Cheng Y, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010; 304(6): 649\u2013656. https:\/\/doi.org\/10.1001\/jama.2010.1111","DOI":"10.1001\/jama.2010.1111"}],"container-title":["Revista Cuidarte"],"original-title":[],"link":[{"URL":"https:\/\/revistas.udes.edu.co\/cuidarte\/article\/download\/2036\/2443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistas.udes.edu.co\/cuidarte\/article\/download\/2036\/2481","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistas.udes.edu.co\/cuidarte\/article\/download\/2036\/2443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T20:11:10Z","timestamp":1727122270000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistas.udes.edu.co\/cuidarte\/article\/view\/2036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":58,"URL":"https:\/\/doi.org\/10.15649\/cuidarte.2036","relation":{},"ISSN":["2216-0973","2346-3414"],"issn-type":[{"value":"2216-0973","type":"print"},{"value":"2346-3414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]}}}